Literature DB >> 4952838

Two early infantile hereditary cases of progressive muscular atrophy simulating dystrophy, but on a neural basis. 1891.

G Werdnig.   

Abstract

Entities:  

Mesh：

Year:  1971        PMID： 4952838     DOI： 10.1001/archneur.1971.00490030102014

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


× No keyword cloud information.
  10 in total

Review 1.  Small Molecules in Development for the Treatment of Spinal Muscular Atrophy.

Authors:  Alyssa N Calder; Elliot J Androphy; Kevin J Hodgetts
Journal:  J Med Chem       Date:  2016-08-16       Impact factor: 7.446

Review 2.  Spinal Muscular Atrophy Modeling and Treatment Advances by Induced Pluripotent Stem Cells Studies.

Authors:  Raffaella Adami; Daniele Bottai
Journal:  Stem Cell Rev Rep       Date:  2019-12       Impact factor: 5.739

3.  Developmental and degenerative cardiac defects in the Taiwanese mouse model of severe spinal muscular atrophy.

Authors:  Gillian K Maxwell; Eva Szunyogova; Hannah K Shorrock; Thomas H Gillingwater; Simon H Parson
Journal:  J Anat       Date:  2018-02-22       Impact factor: 2.610

Review 4.  Spinal muscular atrophy--recent therapeutic advances for an old challenge.

Authors:  Irene Faravelli; Monica Nizzardo; Giacomo P Comi; Stefania Corti
Journal:  Nat Rev Neurol       Date:  2015-05-19       Impact factor: 42.937

5.  Transcriptional enhancement of Smn levels in motoneurons is crucial for proper axon morphology in zebrafish.

Authors:  Zoltán Spiró; Angela Koh; Shermaine Tay; Kelvin See; Christoph Winkler
Journal:  Sci Rep       Date:  2016-06-07       Impact factor: 4.379

6.  Advances in Treatment of Spinal Muscular Atrophy - New Phenotypes, New Challenges, New Implications for Care.

Authors:  David C Schorling; Astrid Pechmann; Janbernd Kirschner
Journal:  J Neuromuscul Dis       Date:  2020

7.  Anesthetic management of spinal muscle atrophy type II in a parturient.

Authors:  Laurent Bollag; Christopher Kent; Philippe Richebé; Ruth Landau
Journal:  Local Reg Anesth       Date:  2011-04-06

Review 8.  Clinical and genetic diversity of SMN1-negative proximal spinal muscular atrophies.

Authors:  Kristien Peeters; Teodora Chamova; Albena Jordanova
Journal:  Brain       Date:  2014-06-25       Impact factor: 13.501

9.  Survival Motor Neuron (SMN) protein is required for normal mouse liver development.

Authors:  Eva Szunyogova; Haiyan Zhou; Gillian K Maxwell; Rachael A Powis; Francesco Muntoni; Thomas H Gillingwater; Simon H Parson
Journal:  Sci Rep       Date:  2016-10-04       Impact factor: 4.379

Review 10.  Alternative Splicing Role in New Therapies of Spinal Muscular Atrophy.

Authors:  Jan Lejman; Grzegorz Zieliński; Piotr Gawda; Monika Lejman
Journal:  Genes (Basel)       Date:  2021-08-28       Impact factor: 4.096
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.